CN105076418A - Infant formula milk powder for promoting development of brain nerves and gastrointestinal tissues of infants - Google Patents

Infant formula milk powder for promoting development of brain nerves and gastrointestinal tissues of infants Download PDF

Info

Publication number
CN105076418A
CN105076418A CN201510505149.XA CN201510505149A CN105076418A CN 105076418 A CN105076418 A CN 105076418A CN 201510505149 A CN201510505149 A CN 201510505149A CN 105076418 A CN105076418 A CN 105076418A
Authority
CN
China
Prior art keywords
milk powder
babies
formula milk
milk
cobastab
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510505149.XA
Other languages
Chinese (zh)
Inventor
刘宁
任皓威
曹宇彤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Northeast Agricultural University
Original Assignee
Northeast Agricultural University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Northeast Agricultural University filed Critical Northeast Agricultural University
Priority to CN201510505149.XA priority Critical patent/CN105076418A/en
Publication of CN105076418A publication Critical patent/CN105076418A/en
Pending legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dairy Products (AREA)

Abstract

The invention discloses infant formula milk powder for promoting the development of brain nerves and gastrointestinal tissues of infants and belongs to the technical field of deep processing of dairy products. Each 100g of the infant formula milk powder contains 11-35mg of cholesterol and 10-11 micrograms of epidermal growth factor (EGF). Aiming at the characteristic that infant formula milk powder in the market commonly does not contain cholesterol, proper amount of high-quality cholesterol is added so that fat of the formula milk powder is relatively close to that of breast milk, and the growth development and maturity of organs, especially the development of brains and nerve systems, of infants are promoted. Meanwhile, the EGF, which can promote proliferation and differentiation of cells, is further added into the infant formula milk powder, so that the development and maturity of the tissues and organs of the infants are facilitated.

Description

A kind of babies ' formula milk powder promoting infant brain nerve and gastrointestinal tissue's growth
Technical field
The present invention relates to a kind of babies ' formula milk powder that infant brain nerve and gastrointestinal tissue grow that promotes, belong to dairy products deep process technology field.
Background technology
Along with improving constantly of human living standard, food such as the formula milk for infant gets most of the attention.Baby needs close attention, a very important great Lei specific group.Himself metabolic system imperfection on the one hand, grows on the other hand and needs to take in appropriate, balanced nutrition.Human milk is the best food of baby, and it is rich in various high-quality protein, fat and multivitamin and mineral matter.But because individual, social cause cause breast milk deficiency or do not have the situation of breast milk.In this case, babies ' formula milk powder arises at the historic moment.In recent years, babies ' formula milk powder is the very welcome a kind of food replacing breast feeding babies.It is a kind of based on cow's milk (or sheep breast), with the addition of the infant formula of the vitamin of applicable baby's needs and the powdery of mineral matter production, its nutritional labeling should be able to meet the nutritional need of normal infant growth and reach similar with each composition in breast milk and content.Along with the development of detection technique, people are further deep to the research of materials all kinds of in breast milk as the composition of protein, lipid, carbohydrate etc., people are by constantly regulating kind and the proportioning of these compositions, improve nutritive value and the biological action of baby formula milk powder, baby formula milk powder is constantly strided forward to breast milk.Cholesterol is one of main composition of human milk lipid components.Cholesterol has certain biological function, as formed cholic acid, forms cell membrane, synthesis multiple types steroid hormone etc.Cholesterol is for the growing and maturation of organ of infant, and especially brain and neural growth are absolutely necessary and can promote the generation of vitamin D.But mostly do not add cholesterol in existing formula milk, this grows obstruction baby's to a certain degree.Have the activated growth factor of a variety of tool in human milk, as EGF EGF, α TGF, β TGF, IGF etc., wherein EGF content is comparatively large, to the material impact that grown of baby.Can promote the Proliferation, Differentiation of cell, the histoorgan being conducive to baby is grown with ripe, can also the growth of stimulating gastrointestinal mucosal microflora and the activity of enhancing intestinal brush border lactase.But, still there is no a kind of baby formula milk powder being rich in cholesterol and EGF at present.
Summary of the invention
For solving the problem, the invention provides a kind of babies ' formula milk powder that infant brain nerve and gastrointestinal tissue grow that promotes, the technical scheme taked is as follows:
The object of the present invention is to provide a kind of babies ' formula milk powder that infant brain nerve and gastrointestinal tissue grow that promotes.Containing the cholesterol of 11 ~ 35mg and the EGF EGF of 10 ~ 11 μ g in every this formula milk of 100g baby.
Preferably, the EGF EGF of 24mg cholesterol and 10.7 μ g is contained in every 100g babies ' formula milk powder.
Preferably, described babies ' formula milk powder also comprises desalted whey powder, Structure grease, lactose, compound sugar, DHA, arachidonic acid, taurine, choline, nucleotides, B B-complex and composite mineral matter.
Babies ' formula milk powder described in claim 3, is characterized in that, described nucleotides, containing 16.16mg in every 100g babies ' formula milk powder, wherein, and AMP3.68mg, GMP1.92mg, CMP8mg, UMP2.56mg.
Preferably, described B B-complex, containing 136.2523mg in every 100g babies ' formula milk powder, comprises dehydroretinol 00 μ g, vitamine D1 0 μ g, vitamin e1 0mg, vitamin K 126.3 μ g, Cobastab 1251 μ g, Cobastab 2385 μ g, Cobastab 6530 μ g, Cobastab 1220 μ g, vitamin C 120mg, nicotinic acid 3000 μ g, pantothenic acid 1000 μ g, folic acid 0.8mg, biotin 30 μ g
Preferably, described composite mineral matter, containing 1698.742mg in every 100g babies ' formula milk powder, comprise zinc 3mg, selenium 12 μ g, iodine 50 μ g, copper 250 μ g, manganese 230 μ g, phosphorus 302mg, sodium 125mg, K42 0mg, calcium 415mg, iron 1.2mg, magnesium 32mg, chlorine 400mg.
Preferably, described Structure grease is, OPO.
Preferably, babies ' formula milk powder described in every 100g is containing, for example lower component:
Desalted whey powder 25g, Structure grease 10g, lactose 8g, FOS 420mg, DHA 1800mg, arachidonic acid 2000mg, dietary fiber 200mg, nucleotides 16.16mg, taurine 28mg, inositol 200mg, choline 180mg, l-cn 12mg, dehydroretinol 00 μ g, vitamine D1 0 μ g, vitamin e1 0mg, vitamin K 126.3 μ g, Cobastab 1251 μ g, Cobastab 2385 μ g, Cobastab 6530 μ g, Cobastab 12in addition to the above components, all the other consist of fresh cow milk spray powder for 20 μ g, vitamin C 120mg, nicotinic acid 3000 μ g, pantothenic acid 1000 μ g, folic acid 0.8mg, biotin 30 μ g, zinc 3mg, selenium 12 μ g, iodine 50 μ g, copper 250 μ g, manganese 230 μ g, phosphorus 302mg, sodium 125mg, K42 0mg, calcium 415mg, iron 1.2mg, magnesium 32mg, chlorine 400mg, cholesterol 24mg, EGF10.7 μ g.
Another object of the present invention is to the preparation method providing a kind of described babies ' formula milk powder, the step of the method is as follows:
1) get fresh milk or goat milk, store 0-5 DEG C of cooling or be directly heated to 40-50 DEG C, then carrying out ungrease treatment, obtaining defatted milk;
2) to step 1) defatted milk of gained carries out sterilization processing, obtains sterilization milk;
3) desalted whey powder, B B-complex, composite mineral matter, lactose, choline, nucleotides, taurine, l-cn, cholesterol and EGF is added; Being preheated to temperature is add Structure grease palmitic acid after 40-60 DEG C, obtains raw material milk;
4) be 40-60 DEG C in temperature, homogenizer pressure under 10-18MPa condition to step 3) gained raw material milk carries out homogeneous process, obtains homogeneous milk;
5) in vacuum to 0.10MPa, temperature is 50-55 DEG C, under pressure < 0.03MPa condition, to step 4) concentrate, obtain concentrated milk;
6) step 5) gained concentrated milk is 15-20MPa at pressure, EAT is 145-170 DEG C, carries out spraying dry when temperature of outgoing air is 70-80 DEG C, obtains baby formula milk powder.
The concrete steps of described method are as follows:
1. fresh milk or 3kg, 0-5 DEG C of cooling storage of sheep breast;
2. degreasing: raw milk is heated to 40-50 DEG C, carries out degreasing with cream-milk separator, requires fat content≤0.2% in skimmed milk, and rare cream cooling preservation gives over to follow-up batching;
3. sterilization: skimmed milk stirring and dissolving is even, is heated to 80-90 DEG C, then carries out being cooled to 65 DEG C;
4. prepare burden: add desalted whey powder, B B-complex, composite mineral matter, lactose, choline, nucleotides, taurine, l-cn, cholesterol and EGF; Being preheated to temperature is 40-60 DEG C, adds the Structure grease such as palmitic acid and rare cream;
5. homogeneous: be 40-60 DEG C in temperature, homogenizer pressure carries out homogeneous to raw milk under 10-18MPa condition
6. concentrate: in vacuum to 0.10MPa, temperature is 50-55 DEG C, under pressure < 0.03MPa condition, concentrates material.
7. spraying dry: be 15-20MPa at pressure, EAT is 145-170 DEG C, carries out spraying dry when temperature of outgoing air is 70-80 DEG C.
Beneficial effect of the present invention:
The babies ' formula milk powder that the present invention is directed on the market does not generally contain this feature of cholesterol, appropriate with the addition of high-quality cholesterol, make the fat constituent of formula milk more press close to breast milk, promote growing and maturation of neonate's organ, especially brain and neural growth.And the cholesterol added can promote the generation of vitamin D in neonate, advantageously in calcareous absorption.Special interpolation growth factor EGF, EGF can promote the Proliferation, Differentiation of cell, the histoorgan being conducive to baby is grown with ripe, can also stimulating gastrointestinal mucosal microflora growth and strengthen the activity of intestinal brush border lactase, thus promoting stomach and intestine growth and gastrointestinal organ's function maturation, intestinal tube is closed.
In formula Design of the present invention except consider that baby needs in growing the most basic three nutritious elements protein, fat, except carbohydrate; with the addition of applicable various age bracket to grow the multivitamin of needs and mineral matter simultaneously; in formula milk, with the addition of the taurine and nucleotides that are conducive to neonatal cerebral and nervous system development, also special interpolation promotes that adipose conversion is the l-cn of energy.
The situation too high for the stearic acid content in baby milk aliphatic acid on the market and linoleic acid content is too low, use new plant oil formula as corn oil, the multiple high-quality refining vegetable oil of sunflower seeds wet goods, have adjusted the proportioning that several important aliphatic acid comprises linoleic acid plus linolenic acid etc., replace some lipid in cow's milk and reduce the content of product polyunsaturated fatty acid, increase monounsaturated fatty acids and content of polyunsaturated fatty acid, more close to breast milk level while enabling the essential fatty acid content in milk powder reach corresponding national standard.Meanwhile, by adding appropriate Structure grease, the structure changing vegetable oil triglycerides makes it more close to human milk fat structure, thus strong prevention neonate constipation, increase the absorption of fat and calcium, promote bone growth.
This formula, for the strong allergenicity of the nondigestible of bovine casein and β lactalbumin, utilizes enzyme to process, and by nondigestible in cow's milk and easily cause irritated albumen to be hydrolyzed modification, its sensitization is even eliminated in reduction, improves the absorptivity to albumen.And adding ALA especially, it is the dominant whey protein in breast milk, and the interpolation of ALA makes formula milk more press close to breast milk in amino acid composition, the activity of stimulating immune system, improves neonatal immunity power.
Detailed description of the invention
Below in conjunction with specific embodiment, the present invention will be further described, but the present invention is not by the restriction of embodiment.
Material therefor, reagent, method and instrument in following examples, without Special Statement, be this area conventional material, reagent, method and instrument, those skilled in the art all obtain by commercial channel.
Embodiment 1
1. fill a prescription
Containing, for example lower component in every 100g formula milk of the present embodiment:
Desalted whey powder 25g, Structure grease 10g, lactose 8g, FOS 420mg, DHA 1800mg, arachidonic acid 2000mg, dietary fiber 200mg, nucleotides 16.16mg, taurine 28mg, inositol 200mg, choline 180mg, l-cn 12mg, dehydroretinol 00 μ g, vitamine D1 0 μ g, vitamin e1 0mg, vitamin K 126.3 μ g, Cobastab 1251 μ g, Cobastab 2385 μ g, Cobastab 6530 μ g, Cobastab 1220 μ g, vitamin C 120mg, nicotinic acid 3000 μ g, pantothenic acid 1000 μ g, folic acid 0.8mg, biotin 30 μ g, zinc 3mg, selenium 12 μ g, iodine 50 μ g, copper 250 μ g, manganese 230 μ g, phosphorus 302mg, sodium 125mg, K42 0mg, calcium 415mg, iron 1.2mg, magnesium 32mg, chlorine 400mg, all the other consist of fresh cow milk spray powder.
The following part by weight of nucleotides described in above-described embodiment: AMP3.68mg; GMP1.92mg; CMP8mg; UMP2.56mg forms, and total amount is 16.16mg.
By the strengthening of l-cn, this formula milk can also be promoted on the basis meeting infant nutrition demand, and baby's energy produces and utilizes DHA, ARA and the aliphatic acid needed for other brain developments better.And the strengthening of l-cn also contributes to helping fat metabolism, advantageously in baby's digesting and assimilating milk powder Middle nutrition material.
2. production method
1. fresh milk or 3kg, 0-5 DEG C of cooling storage of sheep breast;
2. degreasing: raw milk is heated to 40-50 DEG C, carries out degreasing with cream-milk separator, requires fat content≤0.2% in skimmed milk, and rare cream cooling preservation gives over to follow-up batching;
3. sterilization: skimmed milk stirring and dissolving is even, is heated to 80-90 DEG C, then carries out being cooled to 65 DEG C;
4. prepare burden: add desalted whey powder, B B-complex, composite mineral matter, lactose, choline, nucleotides, taurine, l-cn; Being preheated to temperature is 40-60 DEG C, adds the Structure grease such as palmitic acid and rare cream;
5. homogeneous: be 40-60 DEG C in temperature, homogenizer pressure carries out homogeneous to raw milk under 10-18MPa condition
6. concentrate: in vacuum to 0.10MPa, temperature is 50-55 DEG C, under pressure < 0.03MPa condition, concentrates material.
7. spraying dry: be 15-20MPa at pressure, EAT is 145-170 DEG C, carries out spraying dry when temperature of outgoing air is 70-80 DEG C.
Embodiment 2
1. fill a prescription
Containing, for example lower component in every 100g formula milk of the present embodiment:
Desalted whey powder 25g, Structure grease 10g, lactose 8g, FOS 420mg, DHA 1800mg, arachidonic acid 2000mg, dietary fiber 200mg, nucleotides 16.16mg, taurine 28mg, inositol 200mg, choline 180mg, l-cn 12mg, dehydroretinol 00 μ g, vitamine D1 0 μ g, vitamin e1 0mg, vitamin K 126.3 μ g, Cobastab 1251 μ g, Cobastab 2385 μ g, Cobastab 6530 μ g, Cobastab 1220 μ g, vitamin C 120mg, nicotinic acid 3000 μ g, pantothenic acid 1000 μ g, folic acid 0.8mg, biotin 30 μ g, zinc 3mg, selenium 12 μ g, iodine 50 μ g, copper 250 μ g, manganese 230 μ g, phosphorus 302mg, sodium 125mg, K42 0mg, calcium 415mg, iron 1.2mg, magnesium 32mg, chlorine 400mg, special interpolation high-quality cholesterol 11mg, in addition to the above components, this babies ' formula milk powder all the other consist of sweet milk spray powder.
The following part by weight of nucleotides described in above-described embodiment: AMP3.68mg; GMP1.92mg; CMP8mg; UMP2.56mg forms, and total amount is 16.16mg.
2. production method
1. fresh milk or 3kg, 0-5 DEG C of cooling storage of sheep breast;
2. degreasing: raw milk is heated to 40-50 DEG C, carries out degreasing with cream-milk separator, requires fat content≤0.2% in skimmed milk, and rare cream cooling preservation gives over to follow-up batching;
3. sterilization: skimmed milk stirring and dissolving is even, is heated to 80-90 DEG C, then carries out being cooled to 65 DEG C;
4. prepare burden: add desalted whey powder, B B-complex, composite mineral matter, lactose, choline, nucleotides, taurine, l-cn, cholesterol; Being preheated to temperature is 40-60 DEG C, adds the Structure grease such as palmitic acid and rare cream;
5. homogeneous: be 40-60 DEG C in temperature, homogenizer pressure carries out homogeneous to raw milk under 10-18MPa condition
6. concentrate: in vacuum to 0.10MPa, temperature is 50-55 DEG C, under pressure < 0.03MPa condition, concentrates material.
7. spraying dry: be 15-20MPa at pressure, EAT is 145-170 DEG C, carries out spraying dry when temperature of outgoing air is 70-80 DEG C.
Embodiment 3
1. fill a prescription
Containing, for example lower component in every 100g formula milk of the present embodiment:
Desalted whey powder 25g, Structure grease 10g, lactose 8g, FOS 420mg, DHA 1800mg, arachidonic acid 2000mg, dietary fiber 200mg, nucleotides 16.16mg, taurine 28mg, inositol 200mg, choline 180mg, l-cn 12mg, dehydroretinol 00 μ g, vitamine D1 0 μ g, vitamin e1 0mg, vitamin K 126.3 μ g, Cobastab 1251 μ g, Cobastab 2385 μ g, Cobastab 6530 μ g, Cobastab 1220 μ g, vitamin C 120mg, nicotinic acid 3000 μ g, pantothenic acid 1000 μ g, folic acid 0.8mg, biotin 30 μ g, zinc 3mg, selenium 12 μ g, iodine 50 μ g, copper 250 μ g, manganese 230 μ g, phosphorus 302mg, sodium 125mg, K42 0mg, calcium 415mg, iron 1.2mg, magnesium 32mg, chlorine 400mg, special interpolation high-quality cholesterol 35mg, in addition to the above components, this babies ' formula milk powder all the other consist of sweet milk spray powder.
The following part by weight of nucleotides described in above-described embodiment: AMP3.68mg; GMP1.92mg; CMP8mg; UMP2.56mg forms, and total amount is 16.16mg.
2. production method
1. fresh milk or 3kg, 0-5 DEG C of cooling storage of sheep breast;
2. degreasing: raw milk is heated to 40-50 DEG C, carries out degreasing with cream-milk separator, requires fat content≤0.2% in skimmed milk, and rare cream cooling preservation gives over to follow-up batching;
3. sterilization: skimmed milk stirring and dissolving is even, is heated to 80-90 DEG C, then carries out being cooled to 65 DEG C;
4. prepare burden: add desalted whey powder, B B-complex, composite mineral matter, lactose, choline, nucleotides, taurine, l-cn, cholesterol; Being preheated to temperature is 40-60 DEG C, adds the Structure grease such as palmitic acid and rare cream;
5. homogeneous: be 40-60 DEG C in temperature, homogenizer pressure carries out homogeneous to raw milk under 10-18MPa condition
6. concentrate: in vacuum to 0.10MPa, temperature is 50-55 DEG C, under pressure < 0.03MPa condition, concentrates material.
7. spraying dry: be 15-20MPa at pressure, EAT is 145-170 DEG C, carries out spraying dry when temperature of outgoing air is 70-80 DEG C.
Embodiment 4
1. fill a prescription
Containing, for example lower component in every 100g formula milk of the present embodiment:
Desalted whey powder 25g, Structure grease 10g, lactose 8g, FOS 420mg, DHA 1800mg, arachidonic acid 2000mg, dietary fiber 200mg, nucleotides 16.16mg, taurine 28mg, inositol 200mg, choline 180mg, l-cn 12mg, dehydroretinol 00 μ g, vitamine D1 0 μ g, vitamin e1 0mg, vitamin K 126.3 μ g, Cobastab 1251 μ g, Cobastab 2385 μ g, Cobastab 6530 μ g, Cobastab 1220 μ g, vitamin C 120mg, nicotinic acid 3000 μ g, pantothenic acid 1000 μ g, folic acid 0.8mg, biotin 30 μ g, zinc 3mg, selenium 12 μ g, iodine 50 μ g, copper 250 μ g, manganese 230 μ g, phosphorus 302mg, sodium 125mg, K42 0mg, calcium 415mg, iron 1.2mg, magnesium 32mg, chlorine 400mg, special interpolation high-quality cholesterol 24mg, in addition to the above components, this babies ' formula milk powder all the other consist of sweet milk spray powder.
The following part by weight of nucleotides described in above-described embodiment: AMP3.68mg; GMP1.92mg; CMP8mg; UMP2.56mg forms, and total amount is 16.16mg.
2. production method
1. fresh milk or 3kg, 0-5 DEG C of cooling storage of sheep breast;
2. degreasing: raw milk is heated to 40-50 DEG C, carries out degreasing with cream-milk separator, requires fat content≤0.2% in skimmed milk, and rare cream cooling preservation gives over to follow-up batching;
3. sterilization: skimmed milk stirring and dissolving is even, is heated to 80-90 DEG C, then carries out being cooled to 65 DEG C;
4. prepare burden: add desalted whey powder, B B-complex, composite mineral matter, lactose, choline, nucleotides, taurine, l-cn, cholesterol; Being preheated to temperature is 40-60 DEG C, adds the Structure grease such as palmitic acid and rare cream;
5. homogeneous: be 40-60 DEG C in temperature, homogenizer pressure carries out homogeneous to raw milk under 10-18MPa condition
6. concentrate: in vacuum to 0.10MPa, temperature is 50-55 DEG C, under pressure < 0.03MPa condition, concentrates material.
7. spraying dry: be 15-20MPa at pressure, EAT is 145-170 DEG C, carries out spraying dry when temperature of outgoing air is 70-80 DEG C.
Formula milk, after the effect of certification No toxicological, is tested the nursing that mouse carries out two weeks by a definite date with the babies ' formula milk powder of embodiment 1,2,3,4, uses the mouse mean lengths of embodiment 4 babies ' formula milk powder and the growth rate of body weight higher than other three examples.The growth of specific experiment mouse height and weight gain situation are see table 1, table 2.
Embodiment 5
1. fill a prescription
Containing, for example lower component in every 100g formula milk of the present embodiment:
Desalted whey powder 25g, Structure grease 10g, lactose 8g, FOS 420mg, DHA 1800mg, arachidonic acid 2000mg, dietary fiber 200mg, nucleotides 16.16mg, taurine 28mg, inositol 200mg, choline 180mg, l-cn 12mg, dehydroretinol 00 μ g, vitamine D1 0 μ g, vitamin e1 0mg, vitamin K 126.3 μ g, Cobastab 1251 μ g, Cobastab 2385 μ g, Cobastab 6530 μ g, Cobastab 1220 μ g, vitamin C 120mg, nicotinic acid 3000 μ g, pantothenic acid 1000 μ g, folic acid 0.8mg, biotin 30 μ g, zinc 3mg, selenium 12 μ g, iodine 50 μ g, copper 250 μ g, manganese 230 μ g, phosphorus 302mg, sodium 125mg, K42 0mg, calcium 415mg, iron 1.2mg, magnesium 32mg, chlorine 400mg, special interpolation high-quality cholesterol 24mg, growth factor EGF10.7 μ g in addition to the above components, this babies ' formula milk powder all the other consist of sweet milk spray powder.
The following part by weight of nucleotides described in above-described embodiment: AMP3.68mg; GMP1.92mg; CMP8mg; UMP2.56mg forms, and total amount is 16.16mg.
2. production method
1. fresh milk or 3kg, 0-5 DEG C of cooling storage of sheep breast;
2. degreasing: raw milk is heated to 40-50 DEG C, carries out degreasing with cream-milk separator, requires fat content≤0.2% in skimmed milk, and rare cream cooling preservation gives over to follow-up batching;
3. sterilization: skimmed milk stirring and dissolving is even, is heated to 80-90 DEG C, then carries out being cooled to 65 DEG C;
4. prepare burden: add desalted whey powder, B B-complex, composite mineral matter, lactose, choline, nucleotides, taurine, l-cn, cholesterol and growth factor EGF; Being preheated to temperature is 40-60 DEG C, adds the Structure grease such as palmitic acid and rare cream;
5. homogeneous: be 40-60 DEG C in temperature, homogenizer pressure carries out homogeneous to raw milk under 10-18MPa condition
6. concentrate: in vacuum to 0.10MPa, temperature is 50-55 DEG C, under pressure < 0.03MPa condition, concentrates material.
7. spraying dry: be 15-20MPa at pressure, EAT is 145-170 DEG C, carries out spraying dry when temperature of outgoing air is 70-80 DEG C.
Formula milk is after the effect of certification No toxicological, with the babies ' formula milk powder of embodiment 4 and embodiment 5, the nursing that mouse carries out two weeks is by a definite date tested, use the growth rate of the mouse height of embodiment 5 babies ' formula milk powder, body weight all higher than the experimental data that embodiment 4 obtains.The growth of specific experiment mouse height and weight gain situation are see table 1, table 2.
The each embodiment babies ' formula milk powder of table 1 feeds rear mouse mean lengths (cm) growth pattern to mouse
The each embodiment babies ' formula milk powder of table 2 feeds rear average mice body weight (g) Gain weight to mouse
Although the present invention with preferred embodiment openly as above; but it is also not used to limit the present invention, any person skilled in the art, without departing from the spirit and scope of the present invention; can do various change and modification, what therefore protection scope of the present invention should define with claims is as the criterion.

Claims (9)

1. promote to it is characterized in that the babies ' formula milk powder that infant brain nerve and gastrointestinal tissue grow, containing the cholesterol of 11 ~ 35mg and the EGF EGF of 10 ~ 11 μ g in every 100g babies ' formula milk powder.
2. babies ' formula milk powder described in claim 1, is characterized in that, contains the EGF EGF of 24mg cholesterol and 10.7 μ g in every 100g babies ' formula milk powder.
3. babies ' formula milk powder described in claim 1, is characterized in that, also comprises desalted whey powder, Structure grease, lactose, compound sugar, DHA, arachidonic acid, taurine, choline, nucleotides, B B-complex and composite mineral matter.
4. babies ' formula milk powder described in claim 3, is characterized in that, described nucleotides, containing 16.16mg in every 100g babies ' formula milk powder, wherein, and AMP3.68mg, GMP1.92mg, CMP8mg, UMP2.56mg.
5. babies ' formula milk powder described in claim 3, is characterized in that, described B B-complex, containing 136.2523mg in every 100g babies ' formula milk powder, comprises dehydroretinol 00 μ g, vitamine D1 0 μ g, vitamin e1 0mg, vitamin K 126.3 μ g, Cobastab 1251 μ g, Cobastab 2385 μ g, Cobastab 6530 μ g, Cobastab 1220 μ g, vitamin C 120mg, nicotinic acid 3000 μ g, pantothenic acid 1000 μ g, folic acid 0.8mg, biotin 30 μ g.
6. babies ' formula milk powder described in claim 3, it is characterized in that, described composite mineral matter, containing 1698.742mg in every 100g babies ' formula milk powder, comprise zinc 3mg, selenium 12 μ g, iodine 50 μ g, copper 250 μ g, manganese 230 μ g, phosphorus 302mg, sodium 125mg, K42 0mg, calcium 415mg, iron 1.2mg, magnesium 32mg, chlorine 400mg.
7. babies ' formula milk powder described in claim 3, is characterized in that, described Structure grease is, OPO.
8. babies ' formula milk powder described in claim 1; it is characterized in that, every 100g babies ' formula milk powder is containing, for example lower component: desalted whey powder 25g, Structure grease 10g, lactose 8g, FOS 420mg, DHA 1800mg, arachidonic acid 2000mg, dietary fiber 200mg, nucleotides 16.16mg, taurine 28mg, inositol 200mg, choline 180mg, l-cn 12mg, dehydroretinol 00 μ g, vitamine D1 0 μ g, vitamin e1 0mg, vitamin K 126.3 μ g, Cobastab 1251 μ g, Cobastab 2385 μ g, Cobastab 6530 μ g, Cobastab 12in addition to the above components, all the other consist of fresh cow milk spray powder for 20 μ g, vitamin C 120mg, nicotinic acid 3000 μ g, pantothenic acid 1000 μ g, folic acid 0.8mg, biotin 30 μ g, zinc 3mg, selenium 12 μ g, iodine 50 μ g, copper 250 μ g, manganese 230 μ g, phosphorus 302mg, sodium 125mg, K42 0mg, calcium 415mg, iron 1.2mg, magnesium 32mg, chlorine 400mg, cholesterol 24mg, EGF10.7 μ g.
9. a preparation method for babies ' formula milk powder described in claim 1, is characterized in that, step is as follows:
1) get fresh milk or goat milk, store 0-5 DEG C of cooling or be directly heated to 40-50 DEG C, then carrying out ungrease treatment, obtaining defatted milk;
2) to step 1) defatted milk of gained carries out sterilization processing, obtains sterilization milk;
3) desalted whey powder, B B-complex, composite mineral matter, lactose, choline, nucleotides, taurine, l-cn, cholesterol and EGF is added; Being preheated to temperature is add Structure grease palmitic acid after 40-60 DEG C, obtains raw material milk;
4) be 40-60 DEG C in temperature, homogenizer pressure under 10-18MPa condition to step 3) gained raw material milk carries out homogeneous process, obtains homogeneous milk;
5) in vacuum to 0.10MPa, temperature is 50-55 DEG C, under pressure < 0.03MPa condition, to step 4) concentrate, obtain concentrated milk;
6) step 5) gained concentrated milk is 15-20MPa at pressure, EAT is 145-170 DEG C, carries out spraying dry when temperature of outgoing air is 70-80 DEG C, obtains baby formula milk powder.
CN201510505149.XA 2015-08-17 2015-08-17 Infant formula milk powder for promoting development of brain nerves and gastrointestinal tissues of infants Pending CN105076418A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510505149.XA CN105076418A (en) 2015-08-17 2015-08-17 Infant formula milk powder for promoting development of brain nerves and gastrointestinal tissues of infants

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510505149.XA CN105076418A (en) 2015-08-17 2015-08-17 Infant formula milk powder for promoting development of brain nerves and gastrointestinal tissues of infants

Publications (1)

Publication Number Publication Date
CN105076418A true CN105076418A (en) 2015-11-25

Family

ID=54558481

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510505149.XA Pending CN105076418A (en) 2015-08-17 2015-08-17 Infant formula milk powder for promoting development of brain nerves and gastrointestinal tissues of infants

Country Status (1)

Country Link
CN (1) CN105076418A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105638908A (en) * 2016-03-31 2016-06-08 东北农业大学 Formula milk powder for infants of 0-6 months and capable of preventing lactose intolerance and protein allergy
CN105746713A (en) * 2016-03-16 2016-07-13 东北农业大学 Infant formula milk powder capable of promoting development of intestinal mucosal immunity function of newborn
CN106578134A (en) * 2016-12-31 2017-04-26 东北农业大学 Infant formula milk powder for preventing infectious diarrhea
CN107467673A (en) * 2017-07-17 2017-12-15 北京亦贝安生物医药科技有限公司 A kind of compound preparation containing three kinds of unrighted acids and zinc
CN117121949A (en) * 2023-09-22 2023-11-28 广州麦乐生物科技有限公司 Adult formula milk powder for rebuilding and strengthening human immunity

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102422900A (en) * 2011-11-24 2012-04-25 黑龙江飞鹤乳业有限公司 Formula milk powder for promoting absorption of fatty acid and calcium and preparation method thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102422900A (en) * 2011-11-24 2012-04-25 黑龙江飞鹤乳业有限公司 Formula milk powder for promoting absorption of fatty acid and calcium and preparation method thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
关荣发等: "乳品加工中热处理对胰岛素样生长因子-1和表皮生长因子的影晌", 《食品安全监督与法制建设国际研讨会暨第二届中国食品研究生论坛论文集(上)》 *
席会平等: "《食品加工机械与设备》", 31 March 2015, 北京:中国农业大学出版社 *
洪滨: "仿早产儿母乳配方奶粉的研究及其消化率的评价", 《中国优秀硕士学位论文全文数据库·工程科技Ι辑》 *
金焱: "《营养医生的孕产日记》", 30 April 2009, 上海:上海科学技术出版社 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105746713A (en) * 2016-03-16 2016-07-13 东北农业大学 Infant formula milk powder capable of promoting development of intestinal mucosal immunity function of newborn
CN105638908A (en) * 2016-03-31 2016-06-08 东北农业大学 Formula milk powder for infants of 0-6 months and capable of preventing lactose intolerance and protein allergy
CN106578134A (en) * 2016-12-31 2017-04-26 东北农业大学 Infant formula milk powder for preventing infectious diarrhea
CN107467673A (en) * 2017-07-17 2017-12-15 北京亦贝安生物医药科技有限公司 A kind of compound preparation containing three kinds of unrighted acids and zinc
CN107467673B (en) * 2017-07-17 2018-07-03 北京亦贝安生物医药科技有限公司 A kind of compound preparation contained there are three types of unrighted acid and zinc
CN117121949A (en) * 2023-09-22 2023-11-28 广州麦乐生物科技有限公司 Adult formula milk powder for rebuilding and strengthening human immunity

Similar Documents

Publication Publication Date Title
CN100391353C (en) Formula milk powder for babies
CN103564044B (en) A kind of Yoghourt containing marine alga and preparation method thereof
CN105360319A (en) Child development formula milk powder and preparation method thereof
CN105076418A (en) Infant formula milk powder for promoting development of brain nerves and gastrointestinal tissues of infants
CN102422900A (en) Formula milk powder for promoting absorption of fatty acid and calcium and preparation method thereof
CN102389054A (en) Production method of low-cholesterol eggs rich in selenium and vitamin E
CN111802476A (en) Milk powder for improving sleep quality of children and preparation method thereof
CN102389053A (en) Production method of eggs with low cholesterol, abundant selenium and abundant carotene
CN105076425A (en) Yak, cow and ewe three-in-one composite infant formula milk powder
Blažić et al. The impact of traditional cheeses and whey on health
CN103349072A (en) Isolated soybean protein emulsification plant oil type healthcare yoghourt and preparation method thereof
CN113632851A (en) Multifunctional children growth milk powder and preparation method thereof
CN105613972A (en) Vitamin B2 enriched egg production method
CN111642566A (en) Goat milk powder beneficial to children&#39;s height and intelligence development
CN114190441A (en) Formula milk powder for promoting growth and development of children and preparation method thereof
MX2014009719A (en) Methods for making milk-like beverages.
CN103004981A (en) Yoghourt rich in dietary fibers
CN101564174B (en) Protein powder corrected by humanized amino acid spectrum
CN104304174A (en) Vitamin A-rich and vitamin B2-rich egg production method
CN109169927A (en) Calcium-rich yak milk powder, preparation method thereof and fermented milk product
CN105581011A (en) Production method of ALA-rich eggs
CN109845826B (en) Baby milk powder simulating breast milk fatty acid structure and composition
CN102550865A (en) Nutritional regulation and control method for increasing butter-fat content and conjugated fatty acid content of goat milk
CN104304175A (en) Calcium-rich and vitamin B2-rich egg production method
US20210037854A1 (en) Eggs rich in nutrients of alpha-linolenic acid and dha, breeding method of laying hens, and feed additive

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20151125